Polydex Reports First Quarter Financial Results
June 13, 2008 11:50 ET
|
Polydex Pharmaceuticals Limited
TORONTO, June 13, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has today reported financial results of operations for the first quarter of fiscal 2009, ending April 30,...
Polydex Pharmaceuticals Limited -- 2008 Fiscal Year End Results
April 30, 2008 15:01 ET
|
Polydex Pharmaceuticals Limited
TORONTO, April 30, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has announced the results for its fiscal year ended January 31, 2008. All figures are reported in U.S....
Polydex Announces Ushercell Prevents Systemic SHIV Infection in Rhesus Macaques in New Clinical Trial
February 26, 2008 14:02 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Feb. 26, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has completed a clinical trial using rhesus monkeys....
Polydex Pharmaceuticals Receives Staff Deficiency Letter from Nasdaq
January 22, 2008 16:56 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Jan. 22, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announced today that on January 18, 2008, it received a Nasdaq Staff Deficiency Letter from The Nasdaq Stock...
Polydex Pharmaceuticals Provides Third Quarter Report
December 14, 2007 10:13 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2007.
...
Polydex Announces Commencement of Follow-up Study of Ushercell
December 03, 2007 09:53 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Dec. 3, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has commenced a Phase I trial to assess the safety of...
Polydex Moving Forward With Contraceptive Development and Building for the Future
October 01, 2007 09:30 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Oct. 1, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) today issued the following report on Company operations and objectives for the future.
Cash and cash...
Final Report of Ushercell as Treatment for Bacterial Vaginosis Released
September 17, 2007 08:00 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announces that a final report has been received from Dr. Jose Simoes, the Principal Investigator in a Phase...
Polydex Reports Second Quarter Financial Results
September 14, 2007 11:00 ET
|
Polydex Pharmaceuticals Limited
TORONTO, Sept. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports on financial results of operations for the second quarter of fiscal 2008, ending July 31, 2007.
...
Analysis of Ushercell HIV Trials Reveals Difference in Seroconversion Groups Not Statistically Significant
July 25, 2007 07:00 ET
|
Polydex Pharmaceuticals Limited
TORONTO, July 25, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that today at the International AIDS Society 2007 Conference in Sydney Australia, Dr. Lut Van Damme of...